Payload diversification: a key step in the development of antibody–drug conjugates by Louise Conilh, Lenka Sadilkova, Warren Viricel, Charles Dumontet

Get full text

Inhibition of IGF-1 signalling enhances the apoptotic effect of AS602868, an IKK2 inhibitor, in multiple myeloma cell lines. by Ines Tagoug, Amélie Sauty De Chalon, Charles Dumontet

Get full text

Impact of mouse model tumor implantation site on acquired resistance to anti-PD-1 immune checkpoint therapy by Morgane Denis, Morgane Denis, Doriane Mathé, Manon Micoud, Pierre-Antoine Choffour, Chloé Grasselly, Eva-Laure Matera, Charles Dumontet, Charles Dumontet

Get full text

Antibody–Drug Conjugates: The Last Decade by Nicolas Joubert, Alain Beck, Charles Dumontet, Caroline Denevault-Sabourin

Get full text

Real life management of patients hospitalized with multiple myeloma in France. by Charles Dumontet, Sandrine Couray-Targe, Marion Teisseire, Lionel Karlin, Delphine Maucort-Boulch

Get full text

Contribution of Mesenchymal Stem Cells from Obese Adipose Tissue to PD-L1 Over-Expression and Breast Cancer Progression through Pathogenic Th17 Cell Activation by Ferdinand Blangero, Maud Robert, Thomas Andraud, Charles Dumontet, Hubert Vidal, Assia Eljaafari

Get full text

The Antitumor Activity of Combinations of Cytotoxic Chemotherapy and Immune Checkpoint Inhibitors Is Model-Dependent by Chloé Grasselly, Chloé Grasselly, Morgane Denis, Morgane Denis, Aurore Bourguignon, Aurore Bourguignon, Nolan Talhi, Doriane Mathe, Anne Tourette, Laurent Serre, Lars Petter Jordheim, Eva Laure Matera, Charles Dumontet, Charles Dumontet

Get full text

How Can Immune Checkpoint Inhibitors Cause Hyperprogression in Solid Tumors? by Morgane Denis, Morgane Denis, Michael Duruisseaux, Michael Duruisseaux, Marie Brevet, Marie Brevet, Charles Dumontet

Get full text

Virtual screening and biological evaluation of inhibitors targeting the XPA-ERCC1 interaction. by Khaled H Barakat, Lars P Jordheim, Rolando Perez-Pineiro, David Wishart, Charles Dumontet, Jack A Tuszynski

Get full text

Characterization of T‐DM1‐resistant breast cancer cells by Juliette Sauveur, Louise Conilh, Sabine Beaumel, Kamel Chettab, Lars‐Petter Jordheim, Eva‐Laure Matera, Charles Dumontet

Get full text

Exatecan Antibody Drug Conjugates Based on a Hydrophilic Polysarcosine Drug-Linker Platform by Louise Conilh, Guy Fournet, Eric Fourmaux, Angélique Murcia, Eva-Laure Matera, Benoît Joseph, Charles Dumontet, Warren Viricel

Get full text

Spatial and Temporal Control of Cavitation Allows High In Vitro Transfection Efficiency in the Absence of Transfection Reagents or Contrast Agents. by Kamel Chettab, Stéphanie Roux, Doriane Mathé, Emeline Cros-Perrial, Maxime Lafond, Cyril Lafon, Charles Dumontet, Jean-Louis Mestas

Get full text

Beta-hydroxyphosphonate ribonucleoside analogues derived from 4-substituted-1,2,3-triazoles as IMP/GMP mimics: synthesis and biological evaluation by Tai Nguyen Van, Audrey Hospital, Corinne Lionne, Lars P. Jordheim, Charles Dumontet, Christian Périgaud, Laurent Chaloin, Suzanne Peyrottes

Get full text

Synthesis and Evaluation of a Molecularly Imprinted Polymer for Selective Solid-Phase Extraction of Irinotecan from Human Serum Samples by Isabelle Lefebvre-Tournier, Christian Périgaud, Jérome Guitton, Charles Dumontet, Jean-Yves Puy, Charlotte Martin, Sung Vo Duy, Béatrice Roy

Get full text

Structural insights into the inhibition of cytosolic 5'-nucleotidase II (cN-II) by ribonucleoside 5'-monophosphate analogues. by Franck Gallier, Perrine Lallemand, Maïa Meurillon, Lars P Jordheim, Charles Dumontet, Christian Périgaud, Corinne Lionne, Suzanne Peyrottes, Laurent Chaloin

Get full text

A systemically administered detoxified TLR4 agonist displays potent antitumor activity and an acceptable tolerance profile in preclinical models by Kamel Chettab, Kamel Chettab, Chantel Fitzsimmons, Alexey Novikov, Morgane Denis, Morgane Denis, Capucine Phelip, Doriane Mathé, Pierre Antoine Choffour, Sabine Beaumel, Eric Fourmaux, Patrick Norca, David Kryza, Anne Evesque, Lars Petter Jordheim, Emeline Perrial, Eva-Laure Matera, Martine Caroff, Jerome Kerzerho, Charles Dumontet, Charles Dumontet

Get full text

Transcriptional and Metabolic Investigation in 5′-Nucleotidase Deficient Cancer Cell Lines by Octavia Cadassou, Prescillia Forey, Christelle Machon, Edoardo Petrotto, Kamel Chettab, Maria Grazia Tozzi, Jérôme Guitton, Charles Dumontet, Emeline Cros-Perrial, Lars Petter Jordheim

Get full text

A TLR4 Agonist Induces Osteosarcoma Regression by Inducing an Antitumor Immune Response and Reprogramming M2 Macrophages to M1 Macrophages by Iseulys Richert, Paul Berchard, Lhorra Abbes, Alexey Novikov, Kamel Chettab, Alexandra Vandermoeten, Charles Dumontet, Marie Karanian, Jerome Kerzerho, Martine Caroff, Jean-Yves Blay, Aurélie Dutour

Get full text

Dysregulation of ribosome biogenesis and translational capacity is associated with tumor progression of human breast cancer cells. by Stéphane Belin, Anne Beghin, Eduardo Solano-Gonzàlez, Laurent Bezin, Stéphanie Brunet-Manquat, Julien Textoris, Anne-Catherine Prats, Hichem C Mertani, Charles Dumontet, Jean-Jacques Diaz

Get full text

Expression Profiling of Ribosome Biogenesis Factors Reveals Nucleolin as a Novel Potential Marker to Predict Outcome in AML Patients. by Virginie Marcel, Frédéric Catez, Caroline M Berger, Emeline Perrial, Adriana Plesa, Xavier Thomas, Eve Mattei, Sandrine Hayette, Pierre Saintigny, Philippe Bouvet, Jean-Jacques Diaz, Charles Dumontet

Get full text